Tuesday September 25, 2018 20:30

Heathcare Press Release : 12 Mar 2018

The Menarini Group Announced Marketing Authorization Application for Heathcare—12 Mar 18

The Menarini Group announced today that on March 6th 2018 it submitted a Marketing Authorization Application for delafloxacin at the European Medicines Agency (EMA) under the trade name Quofenix. The proposed indication for delafloxacin in Europe is the

Berlinger Resolves Medium-term Withdrawal From the Doping Control Kit Business but Pledges to Help Heathcare—12 Mar 18

The Board of Directors of Berlinger Special AG has resolved that the company will cease production of its doping control kits in the medium term. To avoid jeopardizing current anti-doping activities, the company will continue to supply its present